Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2026-02-02 @ 11:17 PM
Study NCT ID:
NCT01995266
Status:
COMPLETED
Last Update Posted:
2020-08-11
First Post:
2013-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis C | View |
Keywords: